Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haas

Showing results (481-490 of 542) with videos related to

Pageof 55
Sort By:
Pneumologie (Stuttgart, Germany)|April 12, 2016
Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous MycobacteriosesN Schoenfeld, W Haas, E Richter, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011I Solovic, J Jonsson, M Korzeniewska-Koseła, et al.
Human Genetics|January 6, 2026
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in BrazilJacqueline A Piekos, Gustavo Amorim, Felipe Ridolfi, et al.
Pneumologie (Stuttgart, Germany)|February 2, 2012
[Tuberculosis infection control--recommendations of the DZK]R Ziegler, H-M Just, S Castell, et al.
The Journal of Infectious Diseases|May 21, 2013
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmissionSaran Vardhanabhuti, Edward P Acosta, Heather J Ribaudo, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 23, 2012
[Tuberculosis infection control - recommendations of the DZK]R Ziegler, H-M Just, S Castell, et al.
Pharmacogenetics and Genomics|October 29, 2024
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohortGustavo Amorim, James Jaworski, Jing Yang, et al.
Plos One|January 14, 2026
Placebo and nocebo in clinical practice: An online cross-sectional survey of healthcare professionals from European countries on views, practices and training needsMary O'Keeffe, Nathan Skidmore, Arianna Bagnis, et al.
Pharmacogenetics and Genomics|February 17, 2025
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosisNia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, et al.
The Journal of Infectious Diseases|January 29, 2022
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South AfricaDavid W Haas, Mahmoud Tareq Abdelwahab, Stijn W van Beek, et al.
Pageof 55

Showing results (481-490 of 542) with videos related to

Sort By:
Pageof 55
Pneumologie (Stuttgart, Germany)|April 12, 2016
Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous MycobacteriosesN Schoenfeld, W Haas, E Richter, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 6, 2013
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011I Solovic, J Jonsson, M Korzeniewska-Koseła, et al.
Human Genetics|January 6, 2026
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in BrazilJacqueline A Piekos, Gustavo Amorim, Felipe Ridolfi, et al.
Pneumologie (Stuttgart, Germany)|February 2, 2012
[Tuberculosis infection control--recommendations of the DZK]R Ziegler, H-M Just, S Castell, et al.
The Journal of Infectious Diseases|May 21, 2013
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmissionSaran Vardhanabhuti, Edward P Acosta, Heather J Ribaudo, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 23, 2012
[Tuberculosis infection control - recommendations of the DZK]R Ziegler, H-M Just, S Castell, et al.
Pharmacogenetics and Genomics|October 29, 2024
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohortGustavo Amorim, James Jaworski, Jing Yang, et al.
Plos One|January 14, 2026
Placebo and nocebo in clinical practice: An online cross-sectional survey of healthcare professionals from European countries on views, practices and training needsMary O'Keeffe, Nathan Skidmore, Arianna Bagnis, et al.
Pharmacogenetics and Genomics|February 17, 2025
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosisNia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, et al.
The Journal of Infectious Diseases|January 29, 2022
Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South AfricaDavid W Haas, Mahmoud Tareq Abdelwahab, Stijn W van Beek, et al.
Pageof 55